Corticosteroid-Induced Central Serous Chorioretinopathy
DOI:
https://doi.org/10.18196/mm.200142Keywords:
Central Serous Chorioretinopathy, Long term steroid, Methylprednisolone, Mometasone furoateAbstract
Central Serous Chorioretinopathy (CSC) is a condition where there is an accumulation of serous fluid in the retinal pigment epithelium layer. The abnormality in the retinal pigment layer of the eye causes vision loss and serous detachment. CSC has a variety of causes, one of which is corticosteroid therapy. This article aims to report a case of a 27-year-old male patient who was diagnosed with CSC. The risk factor indicating CSC, in this case, was long-term oral and the use of a nasal spray to treat patient’s allergic rhinitis. Patients have allergic rhinitis and sneezing. Thus, they are administered to consume tablets of 16 mg methylprednisolone three times a day. The patient has a history of using a nasal spray containing 0.05% mometasone furoate monohydrate for ten years in a row. The patient’s visual acuity is 6/6 on his right eye and 6/15 on his left eye. Posterior segment examination and optical coherence tomography (OCT) were considered effective in identifying the features of patients with CSC, and thus both were administered. It was further found that steroid therapy replacement and healthier lifestyle adjustments could sustain the symptoms and improve the patient’s well-being.
References
Wang, M., Munch, I. C., Hasler, P. W., Prünte, C., & Larsen, M. Central serous chorioretinopathy. Acta ophthalmologica. 2008, 86(2), 126-145.
Liegl, R., & Ulbig, M. W. Central serous chorioretinopathy. Ophthalmologica. 2014, 232(2), 65-76.
Riaz MT. Different Patterns of Central Serous Chorio-retinopathy on Fundus Fluorescein Angiography. In Islamabad Congress of Ophthalmology. 2017 Apr (Vol. 15, No. 2, p. 65).
Nicholson, B., Noble, J., Forooghian, F., & Meyerle, C. Central serous chorioretinopathy: update on pathophysiology and treatment. Survey of ophthalmology. 2013, 58(2), 103-126.
Schachat, A. P., Wilkinson, C. P., Hinton, D. R., Wiedemann, P., Freund, K. B., & Sarraf, D. Ryan's retina e-book. Elsevier Health Sciences. 2017.
Schubert, H. D., Atebara, N. H., Kaiser, R. S., Martidis, A. A., McCannel, C. A., & Zacks, D. N. Basic and clinical science course, section 12: retina and vitreous, 2014–2015. San Francisco, CA: American Academy of Ophthalmology. 2014.
Ciprandi, G., & Varricchio, A. The relevance of the Mometasone furoate nasal spray in clinical practice. Journal of biological regulators and homeostatic agents, 2018, 32(4), 1051-1054.
Allen, D. B. Sense and sensitivity: assessing inhaled corticosteroid effects on the hypothalamic-pituitary-adrenal axis. Annals of Allergy, Asthma & Immunology, 2002, 89(6), 537-539.
Harrison, T. W., Wisniewski, A., Honour, J., & Tattersfield, A. E. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects. Thorax, 2001, 56(3), 186-191.
Notay, M., Fazel, N., & Awasthi, S. Cushing syndrome induced by topical corticosteroids for the treatment of lichen sclerosus. Journal of pediatric and adolescent gynecology, 2019, 32(1), 83-85.
Hansen, J. S., & Lacourt, P. R. Iatrogenic Cushing's syndrome in a infant due to prolonged use of topical corticosteroids. Case report. Revista chilena de pediatria, 2018, 89(3), 368-372.
Tseng, C. L., Chen, Y. T., Huang, C. J., Luo, J. C., Peng, Y. L., Huang, D. F., ... & Lee, F. Y. Short‐term use of glucocorticoids and risk of peptic ulcer bleeding: a nationwide population‐based case‐crossover study. Alimentary pharmacology & therapeutics, 2015, 42(5), 599-606.
Reinau, D., Schwenkglenks, M., Früh, M., Signorell, A., Blozik, E., & Meier, C. R. Glucocorticoids and the risk of peptic ulcer bleeding: Case–control analysis based on Swiss claims data. Drug safety, 2018, 41(7), 725-730.
Chen, J., & Wall, M. Epidemiology and risk factors for idiopathic intracranial hypertension. International ophthalmology clinics, 2014, 54(1).
Greer, M., & Rangel Guerra, R. Benign Intracranial Hypertension (Cerebral Pseudo-tumor). Medicina universitaria, 2015, 17(66), 2-14.
Spiegel, D. R., Arsani, U., & Le, S. A Case of a Patient with Residual Symptoms of Schizophrenia who Relapsed Following Treatment with the Topical Corticosteroid, Clobetasol: A Review of its Risk of Systemic Absorption and Possibility of Exacerbating Psychosis. Clinical schizophrenia & related psychoses. 2017.
Brusini, P., Tosoni, C., & Zeppieri, M. Canaloplasty in corticosteroid-induced glaucoma. Preliminary results. Journal of clinical medicine, 2018, 7(2), 31.
Hosoda, Y., Hayashi, H., & Kuriyama, S. Posterior subtenon triamcinolone acetonide injection as a primary treatment in eyes with acute Vogt–Koyanagi–Harada disease. British Journal of Ophthalmology, 2015, 99(9), 1211-1214..
Alderaan, K., Sekicki, V., Magder, L. S., & Petri, M. Risk factors for cataracts in systemic lupus erythematosus (SLE). Rheumatology international, 2015, 35(4), 701-708.
O’Keeffe, D. T., Mikhail, M. A., Lanzino, G., Kallmes, D. F., & Weinshenker, B. G. Corticosteroid-induced paraplegia—a diagnostic clue for spinal dural arterial venous fistula. JAMA neurology, 2015, 72(7), 833-834.
Daniel, E., Pistilli, M., Kothari, S., Khachatryan, N., Kaçmaz, R. O., Gangaputra, S. S., ... & Jabs, D. A. Risk of ocular hypertension in adults with noninfectious uveitis. Ophthalmology, 2017, 124(8), 1196-1208.
Anwar, M. A., Saleh, A. I., Al Olabi, R., Al Shehabi, T. S., & Eid, A. H. Glucocorticoid-induced fetal origins of adult hypertension: Association with epigenetic events. Vascular pharmacology, 2016, 82, 41-50.
Tiwari, A., Al-Robeh, H., Sharma, H., Ammari, Z., Khan, M. S., & Jaume, J. C. Steroid-induced diabetic ketoacidosis in a patient with type 2 diabetes mellitus. AACE Clinical Case Reports, 2018, 4(2), e131-e133.
Fathallah, N., Slim, R., Larif, S., Hmouda, H., & Salem, C. B. Drug-induced hyperglycaemia and diabetes. Drug safety, 2015, 38(12), 1153-1168.
Sun, L. Y., & Chu, X. L. Acute myopathy following intra-muscular injection of compound betamethasone: A case report. Medicine, 2017, 96(34).
Mazziotti, G., Formenti, A. M., Frara, S., Doga, M., & Giustina, A. Vitamin D and Glucocorticoid-Induced Osteoporosis. In Vitamin D in Clinical Medicine, 2018, 50, 149-160. Karger Publishers.
Shah, S. P., Desai, C. K., Desai, M. K., & Dikshit, R. K. Steroid-induced central serous retinopathy. Indian journal of pharmacology, 2011, 43(5), 607.
Behar-Cohen, F., & Zhao, M. Corticosteroids and the retina: a role for the mineralocorticoid receptor. Current opinion in neurology, 2016, 29(1), 49-54.
van den Heuvel, M. I., van Assen, M. A., Glover, V., Claes, S., & Van den Bergh, B. R. Associations between maternal psychological distress and salivary cortisol during pregnancy: a mixed-models approach. Psychoneuroendocrinology, 2018, 96, 52-60.
Yeung, L., Lima, V. C., Garcia, P., Landa, G., & Rosen, R. B. Correlation between spectral domain optical coherence tomography findings and fluorescein angiography patterns in diabetic macular edema. Ophthalmology, 2009, 116(6), 1158-1167.
Boyd, S., Brancato, R., & Straatsma, B. Optical coherence tomography: atlas and text. JP Medical Ltd. 2011.
Dakshinamurti, K., Sharma, S. K., & Geiger, J. D. Neuroprotective actions of pyridoxine. Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics, 2003, 1647(1-2), 225-229.
Bacharach, R., Lowden, M., & Ahmed, A. Pyridoxine toxicity small fiber neuropathy with dysautonomia: a case report. Journal of clinical neuromuscular disease, 2017, 19(1), 43-46.
Moudgal, R., Hosseini, S., Colapietro, P., & Awosika, O. Vitamin B6 Toxicity Revisited: A Case of Reversible Pyridoxine-associated Neuropathy and Disequilibrium. (P4. 021). 2018.
van Hunsel, F., van de Koppel, S., van Puijenbroek, E., & Kant, A. Vitamin B 6 in health supplements and neuropathy: case series assessment of spontaneously reported cases. Drug safety, 2019, 41(9), 859-869.
Seth, S., Lewis, A. J., & Galbally, M. Perinatal maternal depression and cortisol function in pregnancy and the postpartum period: a systematic literature review. BMC pregnancy and childbirth, 2016, 16(1), 124.
Mansour, A. M., & Hamam, R. Operating room central serous chorioretinopathy. SAGE open medical case reports, 2017, 5, 2050313X17740052.
Downloads
Published
Issue
Section
License
Copyright
Authors retain copyright and grant Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK) the right of first publication with the work simultaneously licensed under an Attribution 4.0 International (CC BY 4.0) that allows others to remix, adapt and build upon the work with an acknowledgment of the work's authorship and of the initial publication in Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK).
Authors are permitted to copy and redistribute the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK).
License
Articles published in the Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK) are licensed under an Attribution 4.0 International (CC BY 4.0) license. You are free to:
- Share — copy and redistribute the material in any medium or format.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
This license is acceptable for Free Cultural Works. The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
